Loop-Mediated Isothermal Amplification Label-Based Gold Nanoparticles Lateral Flow Biosensor for Detection of Enterococcus faecalis and Staphylococcus aureus by Yi Wang et al.
ORIGINAL RESEARCH
published: 10 February 2017
doi: 10.3389/fmicb.2017.00192
Frontiers in Microbiology | www.frontiersin.org 1 February 2017 | Volume 8 | Article 192
Edited by:
Leonard Peruski,
US Centers for Disease Control and
Prevention, USA
Reviewed by:
Guido Van Marle,
University of Calgary, Canada
Chris Whitehouse,
US Food and Drug Administration,
USA
*Correspondence:
Changyun Ye
yechangyun@icdc.cn
Specialty section:
This article was submitted to
Infectious Diseases,
a section of the journal
Frontiers in Microbiology
Received: 15 December 2016
Accepted: 26 January 2017
Published: 10 February 2017
Citation:
Wang Y, Li H, Wang Y, Zhang L, Xu J
and Ye C (2017) Loop-Mediated
Isothermal Amplification Label-Based
Gold Nanoparticles Lateral Flow
Biosensor for Detection of
Enterococcus faecalis and
Staphylococcus aureus.
Front. Microbiol. 8:192.
doi: 10.3389/fmicb.2017.00192
Loop-Mediated Isothermal
Amplification Label-Based Gold
Nanoparticles Lateral Flow Biosensor
for Detection of Enterococcus
faecalis and Staphylococcus aureus
Yi Wang 1, Hui Li 1, 2, Yan Wang 1, Lu Zhang 1, Jianguo Xu 1 and Changyun Ye 1*
1 State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control
and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for
Disease Control and Prevention, Beijing, China, 2Department of Microbiology, GuiZhou Medical University, Guiyang, China
The report describes a simple, rapid and sensitive assay for visual and multiplex
detection of Enterococcus faecalis and Staphylococcus aureus based on multiple
loop-mediated isothermal amplification (mLAMP) and lateral flow biosensor (LFB).
Detection and differentiation of the Ef0027 gene (E. faecalis-specific gene) and nuc gene
(S. aureus-specific gene) were determined using fluorescein (FITC)-and digoxin-modified
primers in the mLAMP process. In the presence of biotin- and FITC-/digoxin-modified
primers, the mLAMP yielded numerous biotin- and FITC-/digoxin-attached duplex
products, which were detected by LFB through biotin/streptavidin interaction (biotin on
the duplex and streptavidin on the gold nanoparticle) and immunoreactions (FITC/digoxin
on the duplex and anti-FITC/digoxin on the LFB test line). The accumulation of gold
nanoparticles generated a characteristic red line, enabling visual and multiplex detection
of target pathogens without instrumentation. The limit of detection (LoD), analytical
specificity and feasibility of LAMP-LFB technique were successfully examined in pure
culture and blood samples. The entire procedure, including specimen (blood samples)
processing (30 min), isothermal reaction (40 min) and result reporting (within 2 min), could
be completed within 75 min. Thus, this assay offers a simple, rapid, sensitive and specific
test for multiplex detection of E. faecalis and S. aureus strains. Furthermore, the LAMP-
LFB strategy is a universal technique, which can be extended to detect various target
sequences by re-designing the specific LAMP primers.
Keywords: loop-mediated isothermal amplification, lateral flow biosensor, LAMP-LFB, E. faecalis, S. aureus, limit
of detecton
INTRODUCTION
Gram-positive bacteria, especially Enterococcus faecalis (E. faecalis) and Staphylococcus aureus
(S. aureus), are among leading causes of nosocomial infection, such as bloodstream, surgical site
and urinary tract infections (Filetoth, 2008). E. faecalis, which is natural inhabitant of the animal
and human gastrointestinal tract, accounted for 80–90% of all enterococcal-associated infections
(Peel et al., 2012). S. aureus, which is considered part of the normal microflora of microorganisms
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related with skin, throat and nose, is one of the most important
pathogens in hospital- and community-acquired infections
associated with high mortality (Foster et al., 2014). As such,
reliable detection of E. faecalis and S. aureus is important
for accurate diagnosis and instituting adequate antimicrobial
therapy.
The conventional diagnostic assays, such as blood culture,
were used as the gold standard for identifying E. faecalis and
S. aureus, while it took more than 2 days to complete (Peters
et al., 2004). Moreover, the analytical sensitivity of culture-
based methods was markedly reduced if clinical samples were
collected during antimicrobial therapy (Wallet et al., 2010).
PCR and PCR-based detection of target pathogens directly in
clinical samples has been established and was used as a fast
alternative to the traditional culture techniques (Peters et al.,
2007; Wang et al., 2016b). However, PCR-based assays required
specialized apparatus, and these requirements rendered PCR-
based techniques unsuitable for use in field, point-of-care and
resource-poor settings (Jodi Woan-Fei et al., 2015; Wang et al.,
2015c, 2016c). Hence, a simple and specific assay for rapid
diagnosis of the two pathogens is extremely important to institute
adequate antimicrobial therapy, facilitate clinical care, infection
control, and epidemiologic investigations.
The increasing use of molecular diagnostic techniques has
emphasized speed and simplicity as key criteria for adoption
in point-of-care detection, “on-site” testing, field diagnosis
FIGURE 1 | Outline of loop-mediated isothermal amplification. (A) Schematic depiction of the new forward/backward inner primer (FIP*/BIP*) and loop
forward/backward primer amplification primer (LF*/LB*). (B) Outline of loop-mediated isothermal amplification with FIP* and LF*.
and more, and the isothermal amplification technologies were
well-suited for these applications. To date, a wide variety of
isothermal amplification methodologies have been devised for
use inmolecular analyses (Asiello and Baeumner, 2011; Craw and
Balachandran, 2012). Loop-mediated isothermal amplification
(LAMP), as a reliable, sensitive and rapid detection technique,
has been widely applied in many fields, especially in molecular
diagnostics (Mori et al., 2013). The analysis of LAMP products
has become a major concern, since simplifying detection
tools is a major concern. Various monitoring techniques, such
as colorimetric agents, turbidimeters, fluorescent agents, gel
electrophoresis, lab-on-chip devices and lateral flow biosensors
(LFBs), have been employed for analysis of LAMP amplicons
(Zhang et al., 2014). In particular, various LFBs have been
growingly used as alternative tools for analyzing LAMP products
due to their low cost, rapidness, simplicity (Quesada-Gonzalez
and Merkoci, 2015). However, the basic mechanism of LAMP-
LFB technique did not be expounded in previous reports. Most
importantly, these methods were restricted to detecting a single
target, limiting wider application of these techniques.
In the current study, we reported on the development
of a simple, rapid and sensitive molecular technique, which
incorporated LAMP combined with LFB for visual, specific
and multiplex detection of nucleic acid sequence. Here, we
expounded the basic LAMP-LFB principle (Figure 1) and
demonstrated the simplicity and suitability of this assay by
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simultaneously detecting E. faecalis and S. aureus. Then, the
analytical sensitivity, specificity and practicability of LAMP-LFB
assay were determined using pure cultures and spiked blood
samples.
MATERIALS AND METHODS
Reagents and Instruments
The Loopamp kits were purchased from Eiken Chemical.
Co., Ltd. (Beijing, China). The visual detection reagent
(Hydroxynaphthol blue, HNB) was purchased from BeiJing-
HaiTaiZhengYuan Technology Co., Ltd. (Beijing, China). The
QIAamp DNA Mini Kit (QIAamp DNA minikits; Qiagen,
Hilden, Germany) was purchased fromQiagen. Co., Ltd. (Beijing,
China). The Nb.BsrDI was purchased from New England Biolabs
(Beijing, China). The backing card, sample pad, conjugate
pad, nitrocellulose membrane (NC), and absorbent pad were
purchased from the Jie Yi Biotechnology. Co., Ltd. (Shanghai,
China). The streptavidin-immobilized 30 nm gold nanoparticles
(SA-G) was purchased from the Resenbio. Co., Ltd. (XiAn,
China). Sheep anti-digoxigenin antibody (anti-Dig), rabbit anti-
fluorescein antibody (anti-FITC) and biotinylated bovine serum
albumin (biotin-BSA) were purchased from the Abcam. Co., Ltd.
(Shanghai, China).
Preparation of Gold Nanoparticle-Based
Dipstick Biosensor
Lateral flow biosensor (4× 60 mm) was prepared and assembled
as previously described with some modifications (Figure 2)
(Wang et al., 2016a, 2017). Briefly, the biosensor consisted of
four components (the sample pad, conjugate pad, NCmembrane
and absorbent pad), and they were orderly assembled together
on a backing card overlapping 2mm among them. The capture
reagents, including anti-FITC (0.15mg/ml), anti-Dig (0.2mg/ml)
and biotin-BSA (2.5mg/ml) in 0.01M phosphate-buffered saline
(PBS, PH 7.4), were immobilized by physical adsorption on the
reaction regions of the biosensor. On the NC membrane, there
are zones as the test line I (conjugated with anti-FITC), test
line II (conjugated with anti-Dig) and control line (conjugated
with biotin-BSA), with each line separated by 5mm. SA-G in
0.01M PBS (PH 7.4) was impregnated on the conjugate pad of
the biosensor. Then, the whole assembled cards were cut at 0.4 cm
widths by a card cutter (Deli No. 8012) and were packaged in a
plastic box containing a desiccant gel. All biosensors were stored
at the room temperature until use.
Design of the Lamp Primers
Based on the Ef0027 gene (GenBank accession: 1198935)
of E. faecalis and nuc gene (GenBank accession: EF529597)
of S. aureus, two sets of LAMP primers were designed
according to the mechanism of LAMP-LFB technique by using
PrimerExplorer V4 (Eiken Chemical) (Brakstad et al., 1992; Liu
et al., 2005). The specificity of two sets of LAMP primers was
checked using the basic local alignment search tool (BLAST). The
details of primers, primer design, locations and modifications
were shown in Figure S1 and Table 1. All primers were
synthesized by TsingKe. Co., Ltd. (Beijing, China) at HPLC
purification grade.
Bacterial Strains and Genomic DNA
Preparation
A total of 117 strains, which were collected from clinical,
food and environmental samples, were used in this study
(Table 2). These strains were stored in 10% (w/v) glycerol
broth at −70◦C and then were subcultured three times on
nutrient agar plate at 37◦C. The genomic DNA templates were
extracted from all culture strains using DNA extraction kits
(QIAamp DNA minikits; Qiagen, Hilden, Germany) according
to the manufacturer’s instructions. The extracted templates were
tested with ultraviolet spectrophotometer (Nano drop ND-1000,
Calibre, Beijing, China) at A260/280. The templates were stored
under at −20◦C before the templates were used. The strains
of E. faecalis (ATCC 51299) and S. aureus (ICDC Sau-001)
were used for confirmation performance, optimal temperature,
sensitivity analysis and practical application conducted in this
study. The genomic DNA templates of E. faecalis ATCC 51299
FIGURE 2 | Schematic illustration of the principle of lateral flow biosensor for visualization of LAMP products. (A) The test principle of lateral flow
biosensor. A1, aliquots (0.2µl) of LAMP amplicons were deposited on the sample pad of LFB. A2, aliquots (100µl) of running buffer were also deposited on the
sample pad of LFB. A3, The amplicons from target I (E. faecalis) were biotin- and fluorescein-labeled, which were captured by the anti-fluorescein body fixed on the
first line (test line 1, TL1) of LFB. The amplicons from target II (S. aureus) were biotin- and digoxigenin-labeled, which were captured by the anti-digoxigenin body fixed
on the second line (test line 2, TL 2) of LFB. The other end of the double-labeled products labeled with biotin could bind streptavidin-conjugated gold nanoparticles for
visualization. The excess streptavidin-conjugated gold nanoparticles were captured by biotinylated bovine serum albumin fixed on the third line (control line, CL) of
LFB, which demonstrated the working condition of LFB. (B) Interpretation of the results. I, a positive result for target I and II (TL1, TL2, and CL area show red bands);
II, a positive result for target I (TL1 and CL area show red bands); III, a positive result for target II (TL2 and CL area show red bands); VI, negative (only the control line
area shows a red band).
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TABLE 1 | The sequences and modifications of the LAMP primers used in this study.
Primers namea Sequences (5′-3′) and modifications Lengthb Genes
Ef-F3 ACAGAAAGCGATAGTCGTAGT 21 nt
Ef-B3 CCTAAAAATGTTAGCTTTCGTGC 23 nt
Ef-FIP TGGCTTCATCCATTTGTTGAAAACTTTTCAAGCTATTACGCAACAGT 47 mer
Ef-FIP* Biotin-TGGCTTCATCCATTTGTTGAAAACTTTTCAAGCTATTACGCAACAGT 47 mer
Ef-EFIP HEX-TGCAATG-TGGCTT(BHQ-1)CATCCATTTGTTGAAAACTTTTCAAGCTATTACGCAACAGT 53 mer Ef0027
Ef-BIP AAGTCGCGGAAATGCTTAAAATG-GTACAAATAGGAAAACTGCCAC 46 mer
Ef-LF ATCTTGCACATTGGCAATCA 20 nt
Ef-LF* FITC-ATCTTGCACATTGGCAATCA 20 nt
Ef-LB CGATTGAAGTGTTCGGTGT 19 nt
Sau-F3 ATGCAAAGAAAATTGAAGTCGA 22 nt
Sau-B3 GCGTTGTCTTCGCTCCAAAT 20 nt
Sau-FIP CGTTTACCATTTTTCCATCAGCATAGTTTGACAAAGGTCAAAGAACT 47 mer
Sau-FIP* Biotin-CGTTTACCATTTTTCCATCAGCATAGTTTGACAAAGGTCAAAGAACT 47 mer
Sau-EFIP Cy5-TGCAATG-CGTT(BHQ2)TACCATTTTTCCATCAGCATAGTTTGACAAAGGTCAAAGAACT 53 mer Nuc
Sau-BIP TCAAGGCTTGGCTAAAGTTGCTTATTTTCGCTTGTGCTTCACTT 44 mer
Sau-LF TACGCTAAGCCACGTCCATA 20 nt
Sau-LF* Dig-TACGCTAAGCCACGTCCATA 20 nt
Sau-LB CCTAACAATACACATGAACAAC 22 nt
aEf, E. faecalis; Sau, S. aureus. F3, Forward outer primer; FIP, Forward inner primer; LF, Forward loop primer; LB, Backward loop primer; BIP, Backward inner primer; B3, Backward
outer primer; Ef-FIP*, 5’-labeled with biotin when used in LAMP-LFB assay; Ef-LF*, 5’-labeled with FITC when used in LAMP-LFB assay; Sau-FIP*, 5’-labeled with biotin when used in
LAMP-LFB assay; Sau-LF*, 5’-labeled with Dig when used in LAMP-LFB assay.
bmer: monomeric unit; nt: nucleotide.
and S. aureus ICDC Sau-001 were serially diluted 10-fold (2.5
ng, 250 pg, 25 pg, 2.5 pg, 250 fg, 25 fg, and 2.5 fg) for sensitivity
analysis of singlex and multiplex LAMP-LFB detections.
The Standard LAMP Assay
In order to examine the availability of two sets of LAMP
primers, the singlex LAMP reaction either for E. faecalis strains
or S. aureus strains was carried out as the standard LAMP
assay, which has been described in previous report (Wang
et al., 2015b). The amplification mixtures (25µl) consisted of
the following: 0.8 µM each FIP∗ and FIP primers, 1.6µM BIP
primers, 0.8µM each LF∗ and LB primer, 0.4 µM each F3 and
B3 primers, 12.5µl 2 × reaction mix, 1 µl (8 U) of Bst DNA
polymerase and 1µl DNA template. The mixtures were heated
at 62◦C for 1 h and then terminated at 85◦C for 5 min. Mixtures
with 1µl genomic template of Listeria monocytogens strains
(L. monocytogenes, ATCC19114) and Shigella (ICDCNP001)
strains were selected as negative controls, and mixtures with
1 µl double distilled water (DW) were used as a blank
control. Four determination techniques, including colorimetric
indicators (such as HNB reagent), agarose gel electrophoresis,
real-time turbidity and LFB analysis, were employed to monitor
the LAMP amplifications. Moreover, the multiple endonuclease
restriction real-time loop-mediated isothermal amplification
(MERT-LAMP) was employed to achieve real time fluorescence
measurement of LAMP reaction (Wang et al., 2015a).
Then, we tested the optimal amplification temperature of
two sets of LAMP primers, and the LAMP amplifications were
performed at a constant temperature according to the standard
LAMP reaction. Various amplification temperatures ranging
from 60◦C to 67◦C with 1◦C intervals were examined, and
the reactions were monitored by using the Loopamp Real-
time Turbidimeter LA-320 (Eiken Chemical Co., Ltd, Japan). A
positive reaction was defined as a threshold value of >0.1 within
1 h and a mixture without a genomic template was chose as a
negative control.
The Multiplex LAMP Reaction
To ensure the simultaneous amplification of two sets of LAMP
primers in a tube, the MERT-LAMP technology was applied to
adjusting the concentration of the primers (Wang et al., 2015a).
Briefly, each 25-µl MERT-LAMP mixture contained 0.5µM Ef-
EFIP and Ef-FIP primers, 1µM Ef-BIP primer, 0.5µM each Ef-
LF and Ef-LB primers, 0.4µM each Ef-F3 and Ef-B3 primers,
0.8µM Sau-EFIP and Sau-FIP primer, 1.6µM Sau-BIP primer,
0.8µM each Sau-LF and Sau-LB primers, 0.4µM each Sau-F3
and Sau-B3 primers, 12.5µl 2× reaction mix, 1µl (8 U) of Bst
DNA polymerase, 1.5µl (15 U) of Nb.BsrDI endonuclease and
1µl DNA template DNA each of E. faecalis strains and S. aureus
strains. The multiplex MERT-LAMP reactions were conducted
at 62◦C for 1 h in a real-time system. The mixtures without
the genomic DNA template were selected as a negative control.
At least two replicates of each dilution were tested to verify the
sensitivity of multiplex MERT-LAMP reactions.
On the basis, the multiplex LAMP was performed as the
following system: each 25-µl multiplex LAMPmixture contained
0.5µMEf-FIP∗ and Ef-FIP primers, 1µMEf-BIP primer, 0.5µM
each Ef-LF∗ and Ef-LB primers, 0.4µM each Ef-F3 and Ef-B3
primers, 0.8µM Sau-FIP∗ and Sau-FIP primers, 1.6µM Sau-BIP
primer, 0.8µM each Sau-LF∗ and Sau-LB primers, 0.4µM each
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TABLE 2 | Bacteria strains used in the study.
Bacteria Serovara Strain no. (source of
strain)b
No. of
strains
Enterococcus faecalis U ATCC 51299 1
U Isolated strains (ICDC) 29
Staphylococcus aureus U ICDC-NPSau001 1
U ICDC-NPSau002 1
U ICDC-NPSau003 1
U ICDC-NPSau004 1
U ICDC-NPSau005 1
U Isolated strains (ICDC) 25
Enterococcus faecium U ATCC BAA340 1
U Isolated strains (ICDC) 10
Staphylococcus epidermidis U Isolated strains (ICDC) 5
Staphylococcus
saparophytics
U Isolated strains (ICDC) 3
Enterococcus hirae U Isolated strains (ICDC) 1
Streptococcus suis U Isolated strains (ICDC) 1
Streptococcus pneumoniae 19A ATCC 700674 1
14 ATCC 6314 1
Aeromonas hydrophila U Isolated strains (ICDC) 1
Klebsiella pneumoniae U Isolated strains (ICDC) 1
Enteropathogenic E. coli U Isolated strains (ICDC) 1
Enterotoxigenic E. coli U Isolated strains (ICDC) 1
Enteroaggregative E. coli U Isolated strains (ICDC) 1
Enteroinvasive E. coli U Isolated strains (ICDC) 1
Enterohemorrhagic E. coli U Isolated strains (ICDC) 1
Acinetobacter baumannii U Isolated strains (ICDC) 1
Streptococcus sanguis U Isolated strains (ICDC) 1
Streptococcus bovis U Isolated strains (ICDC) 1
Pseudomonas aeruginosa U Isolated strains (ICDC) 1
Campylobacter jejuni U Isolated strains (ICDC) 1
Bntorobater sakazakii U Isolated strains (ICDC) 1
Citro freumdii U Isolated strains (ICDC) 1
Bacillus cereus U Isolated strains (ICDC) 1
Vibrio cholerae U Isolated strains (ICDC) 1
Vibrio parahaemolyticus U Isolated strains (ICDC) 1
Vibrio vulnificus U Isolated strains (ICDC) 1
Yersinia enterocolitica U ATCC 23715 1
Enterobacter cloacae U Isolated strains (ICDC) 1
Salmonella enteric U Isolated strains (ICDC) 1
Shigella flexneri 1d ICDCNPS001 1
Shigella boydii U Isolated strains (ICDC) 1
Listeria monocytogenes 4a ATCC 19114 1
4c ATCC 19116 1
4d ATCC 19117 1
4e ATCC 19118 1
4b ICDC LM419 1
Listeria innocua U ATCC BAA-680 1
Listeria grayi U ATCC 25402 1
(Continued)
TABLE 2 | Continued
Bacteria Serovara Strain no. (source of
strain)b
No. of
strains
Listeria selligeri U ATCC 35967 1
Listerai welshimeri U ATCC 35897 1
Listeria ivanovii U ATCC BAA-678 1
Plesiomonas shigelloides U ATCC 51903 1
aU, unidentified serotype.
bATCC, American Type Culture Collection; ICDC, National Institute for Communicable
Disease Control Disease Control and Prevention, Chinese Center for Disease Control and
Prevention.
Sau-F3 and Sau-B3 primers, 12.5µl 2 × reaction mix, 1µl (8 U)
of BstDNApolymerase, and 1µl template DNA each of E. faecalis
strains and S. aureus strains. The multiplex LAMP reactions also
were conducted at 62◦C for 1 h and at least two replicates of each
dilution were determined.
Analytical Sensitivity of the LAMP-LFB
Assay
In order to examine the analytical sensitivity of singlex and
multiplex LAMP-LFB assays, genomic DNA templates from pure
culture of E. faecalis ATCC 51299 and S. aureus ICDC Sau-001
were serially diluted 10-fold (2.5 ng, 250 pg, 25 pg, 2.5 pg, 250 fg,
25 fg, and 2.5 fg) for confirming the limit of detection (LoD). The
LoD of LAMP-LFB technology was confirmed by DNA amount
of the genomic template. Moreover, a comparative analysis of
LAMP-LFB, qPCR and PCR techniques was conducted in the
study. The E. faecalis-qPCR, E. faecalis-PCR, S. aureus-qPCR,
and S. aureus-PCR assays have been established in previous
studies, which was employed to confirm the LoD of qPCR and
PCR methodologies (Santo Domingo et al., 2003; Peters et al.,
2007).
Evaluation of the Specificity of the
LAMP-LFB Assay
To assess the analytical specificity of the LAMP-LFB
methodology, the multiplex LAMP reactions were performed
under the conditions described above with the genomic DNA
templates from 117 strains (Table 2). Analysis of each sample
was carried out twice independently. Furthermore, the analytical
sensitivity of LAMP-LFB assay was further confirmed using
MERT-LAMP technique.
Practical Application of LAMP-LFB to
E. faecalis and S. aureus Analysis in Blood
Samples
The human blood samples were acquired from a healthy donor
with the written informed consent. Our study was reviewed and
approved by the ethics committee of the National Institute for
Communicable Disease Control and Prevention, China CDC,
according to the medical research regulations of the Ministry of
Health China (Approval No. ICDC2014003).
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To demonstrate the applicability of LAMP-LFB assay, two
strains, including E. faecalis (ATCC 51299) and S. aureus (ICDC-
NPSau001), were applied to test the analytical sensitivity of the
LAMP-LFB in blood samples. Two bacteria suspensions (with
an optical density at 0.6), which contained target E. faecalis
and S. aureus strains, respectively, were prepared in 1000µl of
sterile saline. The numbers of colony forming units (CFU) in the
two suspensions were obtained using a plate-counting technique
according to previous study (Harris et al., 2008). Briefly, serial
10-fold dilution (10−1–10−8) of two suspensions was carried
out, and the aliquots of 100µl appropriate dilution (10−6) were
spread onto blood agar in triplicate and incubated at 37◦C. After
24 h, the numbers of CFU were counted. Then, the aliquots
100µl of each suspension with appropriate dilutions (10−3,
10−4, 10−5, 10−6, 10−7, and 10−8) were simultaneously added
into the blood samples (800µl), and the numbers of E. faecalis
were adjusted to approximate 71000 CFU/ml, 7100 CFU/ml,
710 CFU/ml, 71 CFU/ml, 7.1 CFU/ml and 0.71 CFU/ml, and
S. aureus for 68000 CFU/ml, 6800 CFU/ml, 680 CFU/ml, 68
CFU/ml 6.8 CFU/ml and 0.68 CFU/ml. Aliquots (100µl) of the
artificially contaminated blood samples were subjected to extract
genomic templates, which were eluted in 10µl of Qiagen elution
buffer. Aliquots (2µl) of extracted genomic templates were
used for LAMP-LFB, MERT-LAMP, qPCR and PCR tests. Non-
contamination blood sample was chosen as negative control. This
analysis was independently carried out in twice.
RESULTS
Development of the LAMP-LFB Assay
In the LAMP system (Figure 1B), the forward inner primer
(FIP∗) initiates LAMP amplification at the F2c site of the target
sequence, and the newly synthesized strand is displaced by the
upstream synthesis from the forward primer F3 (Step 1). After 3
primers, including loop forward primer (LF∗), backward inner
primer (BIP) and backward primer (B3), anneal to the newly
synthesized strand (Step 2). Then, the Bst polymerase extends
in tandem yielding two distinct products (Step 3). The LF∗
product acts as the template for further extension by primer
FIP∗, forming a double-labeled detectable product (Step 4). The
end of the target amplicon (FIP∗/LF∗product) was labeled with
biotin, and the other end with hapten. One hapten is assigned to
one LAMP primer set, which offer the possibility for multiplex
LAMP analysis. The details of the amplification process for
BIP product have been descripted in previous reports (Wang
et al., 2015a). Moreover, a double-labeled detectable product
(BIP∗/LB∗), which is similar to the detectable BIP∗/LF∗ product,
can be produced when the BIP primer is labeled with biotin
at the 5′ end and LB primer for hapten. The result readout of
LAMP-LFB assay is shown in Figure 2.
Confirmation and Detection of E. faecalis-
and S. aureus-LAMP-LFB Products
In order to verify the availability of two sets of LAMP primers,
the LAMP amplification mixtures were carried out in the
absence or presence genomic templates according to the standard
condition. The color of the positive amplifications in E. faecalis-
and S. aureus-LAMP tubes changed from violet to blue when
detected with HNB reagents, whereas the color remained violet
in the negative controls and blank tube with 1 h incubation
periods (Figures 3A,B). The LAMP products were analyzed by
2% agarose gel electrophoresis, the ladder-liker patterns were
observed in the positive reactions but not in negative controls
and blank control (Figures 3C,D).Moreover, it was observed that
clear visible red bands in positive amplifications were seen for
the test line I (TL I for E. faecalis detection) and test line II (TL
II for S. aureus detection), only a red band (control line; CL)
was seen in negative and blank controls (Figures 3E,F). These
results demonstrated that the two primer sets were available for
establishment of LAMP-LFB assay for E. faecalis and S. aureus
detection.
Optimal Amplification Temperature of
E. faecalis- and S. aureus-LAMP Primers
To test the optimal reaction temperature of E. faecalis- and
S. aureus -LAMP primers, the E. faecalis- and S. aureus-LAMP
amplifications were conducted at the different temperature (60◦C
to 67◦C) with 1◦C intervals according to the standard condition,
and the strains E. faecalis ATCC 51299 and S. aureus ICDC
Sau-001 were selected as the positive control to examine the
optimal temperature at the level of 25 pg of each template
per tube. The results were analyzed by means of real time
turbidity detection. The typical kinetics graphs were generated
from the eight temperatures, with the faster reactions observed
for approach temperature of 61◦C to 66◦C for the E. faecalis-
LAMP reactions and 61◦C to 64◦C for S. aureus-LAMP reactions
(Figure 4). The reaction temperature of 62◦C was used for the
rest of singlex and multiplex-LAMP amplifications carried out in
this report.
Sensitivity of LAMP-LFB Detection for a
Single Target
The serial dilutions (2.5 ng, 250 pg, 25 pg, 2.5 pg, 250 fg,
25 fg, and 2.5 fg per microliter) of the total genomic DNA
were used as templates to determine the analytical sensitivity
of E. faecalis- and S. aureus-LAMP-LFB assays. The limit
of detection (LoD) of LAMP-LFB assays for independently
detecting Ef0027 (E. faecalis-specific gene) and nuc (S. aureus-
specific gene) sequences was 250 fg of genomic templates per
reaction (Figures 5, 6). As expected, the biosensor showed clear
visible red bands for both TL I and CL when the products
came from positive E. faecalis-LAMP reactions, and only the
CL was seen for negative E. faecalis-LAMP reactions and blank
control (Figure 5A). Likewise, the biosensor also displayed clear
visible red bands for both TL II and CL when the products
came from positive S. saures-LAMP reactions, and only the
CL was seen for S. saures-LAMP reactions and blank control
(Figure 6A). The LoD of LAMP-LFB method for independently
detecting Ef0027 gene or nuc gene was 250 fg per reaction.
The positive E. feacalis- and S. aureus-LAMP products by 2%
agarose gel electrophoresis were observed as the ladder-like
patterns but not in negative reactions and blank control, and the
LoD of the agarose gel electrophoresis detection for E. feacalis-
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FIGURE 3 | Detection and confirmation of E. faecalis- and S. aureus-LAMP products. (A,B) Color change of E. faecalis- and S. aureus-LAMP tubes;
(C,D) 2%agarose gel electrophoresis applied to E. faecalis- and S. aureus-LAMP products; (E,F), LFB applied for visual detection of E. faecalis- and S. aureus-LAMP
products. Tube A1 (lane C1, biosensor E1), positive amplification; tube A2 (lane C2, biosensor E2), negative amplification (S. aureus), tube A3 (lane C3, biosensor E3),
negative amplification (L. monocytogenes), tube A4 (lane C4, biosensor E4), negative amplification (Shigella), tube A5 (lane C5, biosensor E5), blank control (DW);
Tube B1 (lane D1, biosensor F1), positive amplification; tube B2 (lane D2, biosensor F2), negative amplification (E. faecalis), tube B3 (lane D3, biosensor F3), negative
amplification (L. monocytogenes), tube B4 (lane D4, biosensor F4), negative amplification (Shigella), tube B5 (lane D5, biosensor F5), blank control (DW); Lane M, DL
50-bp DNA marker.
and S. aureus-LAMP amplification was consist with biosensor
analysis (Figures 5B, 6B).
Three monitoring techniques, including colorimetric
indicators (such as HNB reagent), turbidimeters and MERT-
LAMP analysis, were applied to further verifying the assay
sensitivity. By HNB reagent, a color shift of positive reaction in
E. faecalis- and S. aureus-LAMP tubes was directly seen from
violet to blue (Figures 5C, 6C). The E. faecalis- and S. aureus-
LAMP reactions were analyzed by real time measurement of
turbidity and the LoD of E. faecalis- and S. aureus-LAMP
method for independently detecting Ef0027 gene or nuc gene was
250 fg per reaction (Figures 5D, 6D). By real time fluorescence
analysis, the sensitivity of E. faecalis- and S. aureus-MERT-LAMP
approaches for independently detecting Ef0027 gene or nuc gene
was also 250 fg per reaction (Figures 5E, 6E). These results
indicated that the assay sensitivity by agarose gel electrophoresis,
real time turbidity, HNB reagent, and real time fluorescence
detection for E. faecalis- and S. aureus-LAMP amplifications was
in conformity with LFB analysis (Figures 5, 6). Moreover, the
LoD of E. faecalis- and S. aureus-LAMP-LFB assay was 10- and
100-fold more sensitive than that of the qPCR and PCR assays
(Figures 5, 6 and Table 3).
Sensitivity of LAMP-LFB Detection of
Multiple Targets in a Reaction
According to multiplex MERT-LAMP reaction, the
concentration of two sets of LAMP primers was adjusted
to facilitate the simultaneous amplification in a vessel and
guarantee the generation of reliable multiplex LAMP products.
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FIGURE 4 | The optimal amplification temperature for LAMP reactions. The standard LAMP reactions for detection of E. faecalis (A) and S. aureus (B) were
monitored by real-time measurement of turbidity and the corresponding curves of concentrations of DNA were marked in the figures. The threshold value was 0.1 and
the turbidity of >0.1 was considered to be positive. Eight kinetic graphs (1–8) were generated at various temperatures (60–67◦C, 1◦C intervals) with target pathogens
DNA at the level of 25 pg per reaction. (A) The graphs from 2 to 7 showed robust amplification; (B) the graphs from 2 to 4 showed robust amplification.
Two different fluorescence curves were simultaneously yielded
frommultiplex MERT-LAMP reactions containing two complete
MERT-LAMP primer sets and their corresponding genomic
templates (Figure S2). Hence, the multiplex MERT-LAMP
system was able to simultaneously amplify and correctly identify
Ef0027 gene and nuc gene in a single tube.
Instead of Ef-EFIP, Ef-LF, Sau-EFIP, and Sau-LF primers in
multiplex MERT-LAMP system, the Ef-FIP∗, Ef-LF∗, Sau-FIP∗,
and Sau-LF∗ primers were added into the multiplex LAMP
amplification mixture for replicating all possible target sequences
and labeling all the possible target amplicons. After multiplex
LAMP, the reaction mixtures were directly detected using the
biosensor. Three visible red lines, including TL I, TL II, and
CL, appeared on the biosensor, suggesting positive results for
two target organisms, whereas only a visible band at the control
zone appeared, suggesting negative results at the concentrations
lower than 250 fg of DNA templates per vessel and blank control
(Figure 7). Therefore, the assay sensitivity of multiplex LAMP-
LFB technique for simultaneously identifying Ef0027 and nuc
genes was also 250 fg of DNA templates per reaction, which
was in complete accordance with the singlex E. faecalis- and
S. aureus-LAMP-LFB detection.
The Optimal Duration of Time Require for
LAMP-LFB Assay
On the basis of multiplex LAMP-LFB method, we examined
the optimal duration of time require for the multiplex LAMP-
LFB detection during the amplification stage, and six distinct
reaction times (10, 20, 30, 40, 50, and 60 min) were compared
at 62◦C. The lowest DNA levels (250 fg of E. faecalis and
S. aureus templates) exhibited three visible red lines when the
reaction lasted for 40 min at 62◦C, thus a amplification time of
40 min was recommended as the optimal time for the LAMP-
LFB method during the amplification stage (Table 4). Herein,
the whole process, including sample (such as blood sample)
processing (30 min), amplification (40 min) and result indicating
(2 min), could be finished within 75 min.
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FIGURE 5 | Analysis of a single target in a standard LAMP reaction. LAMP primers targeting the Ef0027 (E. faecalis) gene were used in standard reactions and
the serial dilutions (2.5 ng, 250 pg, 25 pg, 2.5 pg, 250 fg, 25 fg, and 2.5 fg) of target templates were subjected to LAMP amplification. (A) LFB applied for visual
detection of E. faecalis-LAMP products. (B) 2% agarose gel electrophoresis applied to E. faecalis-LAMP products. (C) HNB applied for visual detection of
E. faecalis-LAMP products. (D) Real-time turbidity applied for detection of E. faecalis-LAMP products. (E) Real-time fluorescence applied for detection of
E. faecalis-LAMP products. Biosensors/lanes/tubes/turbidity signals/ fluorescence signals 1-7, E. faecalis genomic DNA (2.5 ng-2.5 fg), biosensor/lane/tube/turbidity
signal/ fluorescence signal 8, blank control (DW).
Analytical Specificity of Multiplex
LAMP-LFB Assay
The assay specificity of the LAMP-LFB assay was evaluated using
extracted genomic templates (Roughly 3 ng of genomic templates
for each pathogen) from 30 E. faecalis, 30 S. aureus, 57 non-
E. faecalis and non-S. aureus strains (Table 2). The positive
results were specifically yielded only when genomic DNAs of
E. faecalis and S. aureus strains were used as templates. As
shown in Figure 8, two red lines (TL I and CL) appeared on
the strip, suggesting positive results for all E. faecalis strains,
whereas TL II and CL appeared on the biosensor, indicating
positive results for all S. aureus strains. Only a visible red
line (CL) at the control zone appeared, suggesting negative
results for non-E. faecalis, non-S. aureus strains and blank
control. The multiplex LAMP-LFB assay established here was
able to correctly distinguish and simultaneously detect two target
pathogens in a reaction. Furthermore, the analytical specificity
of multiplex LAMP-LFB assay was further demonstrated using
the multiplex MERT-LAMP technique (Figure S3). Hence,
these results suggested that the multiplex LAMP-LFB approach
described here was feasible to target sequence detection and
differentiation.
Examination of LAMP-LFB Assay for
Artificially Contaminated Blood Sample
In order to demonstrate the usability of LAMP-LFB assay as
a detection tool for diagnosing E. faecalis and S. aureus, the
LAMP-LFB method was evaluated by the artificially inoculating
E. faecalis and S. aureus strain into the blood samples. The
multiplex LAMP-LFB method generated positive results when
the contaminated numbers of E. faecalis and S. aureus more
than 710 CFU/ml (∼14.2 CFU/reaction) and 680 CFU/ml (∼13.6
CFU/reaction), respectively, and the target pathogens could be
simultaneously detected and correctly distinguished in a blood
sample (Figure 9, Table 5). The non-contaminated blood sample
was seen to be negative.
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FIGURE 6 | Analysis of a single target in a standard LAMP reaction. LAMP primers targeting the nuc (S. aureus) gene were used in standard reactions and the
serial dilutions (2.5 ng, 250 pg, 25 pg, 2.5 pg, 250 fg, 25 fg, and 2.5 fg) of target templates were subjected to LAMP amplification. (A) LFB applied for visual detection
of S. aureus-LAMP products. (B) 2%agarose gel electrophoresis applied to S. aureus-LAMP products. (C) HNB applied for visual detection of S. aureus-LAMP
products. (D) Real-time turbidity applied for detection of S. aureus-LAMP products. (E) Real-time fluorescence applied for detection of S. aureus-LAMP products.
Biosensors/lanes/tubes/turbidity signals/ fluorescence signals 1-7, S. aureus genomic DNA (2.5 ng-2.5 fg), biosensor/lane/tube/turbidity signal/ fluorescence signal 8,
blank control (DW).
TABLE 3 | The sensitivity for singlex LAMP-LFB reaction targeting Ef0027
and nuc genes compared with that of qPCR and conventional PCR assays.
Approachesa Isothermal
amplification
Regions
recognized
Multiplex
detection
LoD for E. faecalis/
S. aureus
(no./reaction)b
LAMP-LFB + 8 + 250 fg/250 fg
qPCR − 3 + 2.5 pg/2.5 pg
PCR − 2 + 25 pg/25 pg
aLAMP, loop-mediated isothermal amplification; LFB, lateral flow biosensor; qPCR,
quantitative real-time PCR.
bLoD, limit of detection.
The LoD of multiplex LAMP-LFB methodology was identical
with that of multiplex MERT-LAMP detection for E. faecalis or
S. aureus in artificially contaminated blood sample (Figure S4,
Table 5). Comparatively, the analytical sensitivity of multiplex
LAMP-LFB technique was 10- and 100-fold more sensitivity than
that of qPCR and PCR methods, respectively (Table 5). The
qPCR technique yielded positive results when the contaminate
numbers of E. faecalis and S. aureus amounted to more
than 7100 CFU/ml (∼142 CFU/reaction) and 6800 CFU/ml
(∼136 CFU/reaction), conventional PCR assay for 71000
CFU/ml (∼1420 CFU/reaction) and 68000 CFU/ml (∼1360
CFU/reaction), respectively.
DISCUSSION
E. faecalis and S. aureus are two important bacterial pathogens
in nosocomial infections, such as surgical site, urinary tract and
bloodstream infections (Filetoth, 2008). Thus, rapid, sensitive
and reliable detection of E. faecalis and S. aureus is essential
in decreasing the risk factor caused by the two pathogens.
This report describes a sensitive LAMP-LFB method for specific
detection and accurate identification of the two target organisms
in a single assay. Comparing with the existent PCR-based
methodologies, the LAMP-LFB method was conducted at a
Frontiers in Microbiology | www.frontiersin.org 10 February 2017 | Volume 8 | Article 192
Wang et al. LAMP-LFB for Detection of Enterococcus faecalis and Staphylococcus aureus
FIGURE 7 | Visual detection of multiplex targets in a multiplex LAMP reaction. Two sets of MCDA primers targeting Ef0027 and nuc genes were
simultaneously added to a reaction tube and the sensitivity of multiplex LAMP for simultaneously detecting E. faecalis and S. aureus was analyzed by visual format.
Biosensors 1, 2, 3, 4, 5, 6, 7, and 8 represent DNA levels of 2.5 ng (each of E. faecalis and S. aureus templates), 250 pg (each of E. faecalis and S. aureus templates),
25 pg (each of E. faecalis and S. aureus templates), 2.5 pg (each of E. faecalis and S. aureus templates), 250 fg (each of E. faecalis and S. aureus templates), 25 fg
(each of E. faecalis and S. aureus templates), 2.5 fg (each of E. faecalis and S. aureus templates) and blank control (DW). The LoD of multiplex LAMP-LFB assay for
E. faecalis and S. aureus detection was 250 fg per reaction.
TABLE 4 | Optimal duration of time required for the multiplex LAMP-LFB
assaya.
Time/min DNA dilution for E. faecalis/S. aureus (no./µl)
2.5 ng 250 pg 25 pg 2.5 pg 250 fg 25 fg 2.5 fg BCc
10 −/− −/− −/− −/− −/− −/− −/− −/−
20 +/+ +/+ +/+ −/− −/− −/− −/− −/−
30 +/+ +/+ +/+ +/+ +/+b −/− −/− −/−
40 +/+ +/+ +/+ +/+ +/+ −/− −/− −/−
50 +/+ +/+ +/+ +/+ +/+ −/− −/− −/−
60 +/+ +/+ +/+ +/+ +/+ −/− −/− −/−
aThree replications were performed for each trial.
bThe result was weakly positive.
cBC, blank control.
constant temperature during the amplification stage, eliminating
the use of a costly specialized apparatus, and only a simple water
bath or heat blocker was needed to perform the reaction. Herein,
the LAMP-LFB assay established here has potential for “on-site”
detection, field test, point-of-care diagnosis and more.
The LAMP-LFB method only required an incubation time of
40 min during the reaction stage (Table 4). The amplification
products were directly detected using the biosensor, and
result indicating could be finished within 2 min. Analysis
of LAMP products with a lateral flow biosensor is not
only speedy, but also less error-prone and simpler than
analysis by the other monitoring techniques (colorimetric
indicators, agarose gel electrophoresis, real-time turbidity and
fluorescence measurement) employed in the current report
(Figures 3, 5, 6). Consequently, the whole procedure, including
specimen processing (30 min), incubation (40 min) and analysis
(2 min), could be competed with 75 min. Thus, the rapid
identification of target pathogens was valuable for determining
the choice of rational therapy in clinical laboratories.
Although, many previous studies have applied LFB for
the analysis of LAMP amplicons, the basic mechanism did
not be depicted (Kiatpathomchai et al., 2008; Njiru, 2012;
Kaewphinit et al., 2013; Yin et al., 2016). To the best of our
knowledge, this is first report expounding the basic LAMP-
LFB principle and providing the details on biosensor detection
(Figures 1, 2). In the LAMP-LFB system, FIP∗ or BIP∗ primer,
which involved in isothermal amplification, was labeled with
biotin at the 5′ end. LF∗ or LB∗ primer was labeled with
hapten at the 5′ end. During the reaction stage, the double-
labeled detectable products were formed, which were yielded
from biotin-labeled FIP∗ (BIP∗) primers and hapten-labeled LF∗
(LB∗) primers. One hapten was assigned to one target primer
set, thus LAMP-LFB method permitted detection of multiple
nucleic acid sequences in a single reaction using the FIP∗(BIP∗)
and LF∗(LB∗) primers. The amplicons from target I (E. faecalis)
were biotin- and fluorescein-labeled, which derived from biotin-
labeled FIP∗ primer and fluorescein-labeled LF∗ primer, and were
captured by the anti-fluorescein body fixed on the first line of
LFB, known as the test line I. The amplicons from target II
(S. aureus) were biotin- and digoxigenin-labeled, which derived
from biotin-labeled FIP∗ primer and digoxigenin-labeled LF∗
primer, and were captured by the anti-digoxigenin body fixed
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FIGURE 8 | The specificity of multiplex LAMP assay for different strains. The multiplex LAMP reactions were conducted using different genomic DNA
templates and were monitored by means of visual format. Biosensors 1-3, strains of E. faecalis (ATCC 51299), E. faecalis (ICDC-NPEf001), E. faecalis
(ICDC-NPEf002); biosensors 4-9, S. aureas (ICDC-NPSau001), S. aureas (ICDC-NPSau002), S. aureas (ICDC-NPSau003), S. aureas (ICDC-NPSau004), S. aureas
(ICDC-NPSau005), S. aureas (Isolated strain); biosensors 13-35, non-S. aureas, non-E. faecalis strains of Enterococcus faecium (ATCC BAA340), Staphylococcus
epidermidis, Staphylococcus saparophytics, Enterococcus hirae, Streptococcus suis, Streptococcus pneumonia, Aeromonas hydrophila, Klebsiella pneumonia,
Enteroinvasive E. coli, Enteropathogenic E. coli, Enterotoxigenic E. coli, Enteroaggregative E. coli, Enterohemorrhagic E. coli, Acinetobacter baumannii, Streptococcus
sanguis, Streptococcus bovis, Pseudomonas aeruginosa, Campylobacter jejuni, Bntorobater sakazakii, Citro freumdii, Bacillus cereus, Shigella flexneri and Listeria
monocytogenes; biosensor 36, blank control.
FIGURE 9 | Analytical sensitivity of LAMP-LFB for simultaneously detecting two target pathogens in artificially contaminated blood samples. Two sets
of LAMP primers targeting Ef0027 and nuc genes were simultaneously added to a reaction vessel. Sensitivity of LAMP-LFB assay for simultaneously detecting
E. faecalis and S. aureus in artificially contaminates blood samples was analyzed by visual format. The biosensors 1, 2, 3, 4, 5, and 6 represent E. faecalis DNA levels
of 14200 CFU, 1420 CFU, 142 CFU, 14.2 CFU, 1.42 CFU, and 0.142 CFU per reaction; S. aureus DNA levels for 13600 CFU, 1360 CFU, 136 CFU, 13.6 CFU, 1.36
CFU, and 0.136 CFU per reaction, and the biosensor 7 represent negative control (non-contaminated blood samples). The LoD of LAMP-LFB method for E. faecalis
analysis in artificially contaminates blood samples was 14.2 CFU per reaction, and the LoD of LAMP-LFB for S. aureus detection in artificially contaminates blood
samples was 13.6 CFU per reaction.
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TABLE 5 | Comparison of LMAP-LFB, qPCR and PCR assay for detection
of E. faecalis and S. aureus in artificially contaminated blood samples.
Detection
methodsa
Multiplex
detection
LoD (no./reaction)
E. faecalis detection S. aureus
detection
LAMP-LFB + 14.2 CFU ∼
(7.1 × 102 CFU/ml)
13.6 CFU ∼
(6.8 × 102 CFU/ml)
qPCR − 142 CFU ∼
(7.1 × 103 CFU/ml)
136 CFU ∼
(6.8 × 103 CFU/ml)
PCR − 1420 CFU ∼
(7.1 × 104 CFU/ml)
1360 CFU ∼
(6.8 × 104 CFU/ml)
aLAMP, loop-mediated isothermal amplification; LFB, lateral flow biosensor; qPCR,
quantitative real-time PCR.
on the second line of LFB, known as the test line II. The other
end of the double-labeled products labeled with biotin could bind
streptavidin-conjugated gold nanoparticles for visualization. The
excess streptavidin-conjugated gold nanoparticles were captured
by biotinylated bovine serum albumin fixed on the third line of
LFB, known as the control line, which demonstrated the working
condition of LFB.
Two species-specific genes (Ef0027 and nuc) present in both
E. faecalis and S. aureuswere selected as target genes for designing
the LAMP-LFB primers (Brakstad et al., 1992; Liu et al., 2005).
A total of 117 strains (30 E. faecalis, 30 S. aureus, 57 non-
E. faecalis and non-S. aureus strains) were applied to determining
the assay specificity, and the LAMP-LFB assay achieved 100%
inclusivity and 100% exclusivity. Positive reactions were seen in
the assay of E. faecalis strains and S. aureus strains, but not for
non-E. faecalis strains and non-S. aureus strains. Moreover, the
LAMP-LFB assay described here could simultaneously diagnose
and correctly differentiate the two pathogens in a sample,
which was conducted at a fixed temperature (62◦C) with easily
interpretable results (Figure 8). These results indicated that the
LAMP-LFB technology developed here was specific to E. faecalis
and S. aureus detection.
In additional to its high specificity, the analytical sensitivity of
LAMP-LFBmethod was assessed using serial dilution of genomic
templates. We examined the LAMP-LFB assay in a single target
format by using separate amplification of Ef0027 (E. faecalis-
specific gene) and nuc (S. aureus-specific gene) from E. faecalis
and S. aureus genomic templates. The analytical sensitivity of
LAMP-LFB technique for independently analyzing Ef0027 gene
or nuc gene was 250 fg genomic DNA templates per tube,
which was 10- and 100-fold more sensitive than that of the
qPCR and PCR approaches (Figures 5, 6 and Table 3). Moreover,
the multiplex LAMP-LFB method provided the robust data of
analytical sensitivity, which was similar to singlex LAMP-LFB
reaction (Figures 5–7). The analytical sensitivity of multiplex
LAMP-LFB to simultaneously detect Ef0027 and nuc genes was
250 fg of genomic DNA templates each reaction, which was in
conformity with that of singlex LAMP-LFB detections. Although,
the LAMP products could be analyzed equally with other four
techniques employed in the current study, lateral flow biosensor
is likely the preferred technique as the indicating the results
is less subjective and does not rely on expensive reagents and
complicated instrumentation.
In spiked blood samples, the LoD of 14.2 E. faecalis
CFU/reaction and 13.6 S. aureus CFU/reaction was found for
multiplex LAMP-LFB assays, which translated to 710 E. faecalis
CFU/ml and 680 S. aureus CFU/ml of blood sample, respectively
(Figure 9, Table 5). In contrast, the detection limit of qPCR
approaches was 142 E. faecalis CFU/reaction (∼7.1 × 103
CFU/ml) and 136 S. aureus CFU/reaction (∼6.8× 103 CFU/ml),
and conventional PCRmethods for 1420 E. faecalisCFU/reaction
(∼7.1 × 104 CFU/ml) and 1360 S. aureus CFU/reaction
(∼6.8 × 104 CFU/ml), suggesting that multiplex LAMP-LFB
methodologies were 10- and 100-fold more sensitive than qPCR
and PCR technologies for detection of two target pathogens in
spiked blood samples.
In conclusion, a LAMP-LFB assay was successfully established
for detection of E. faecalis and S. aureus, causing nosocomial
infection, such as bloodstream, surgical site and urinary tract
infections. LAMP-LFB assay is simple, sensitive and specific,
allowing multiplex and visual analysis of multiple targets in a
single reaction. The use of LFB offers a rapid, objective and easily
interpretable readout of the assay’s results, which eliminates the
use of expensive reagents and special apparatus. Thus, the LAMP-
LFB technique is a valuable tool for identifying target pathogens
in clinical, point-of-care and resource-poor settings. Moreover,
the proof-of-concept strategy (LAMP-LFB) may be reconfigured
to detect various biomarkers by re-designing the specific LAMP
primers.
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